Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
Marshall AD, Willing AR, Kairouz A, Cunningham EB, Wheeler A, O'Brien N, Perera V, Ward JW, Hiebert L, Degenhardt L, Hajarizadeh B, Colledge S, Hickman M, Jawad D, Lazarus JV, Matthews GV, Scheibe A, Vickerman P, Dore GJ, Grebely J; Global HCV and HIV Treatment Restrictions Group. Marshall AD, et al. Among authors: wheeler a. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):366-382. doi: 10.1016/S2468-1253(23)00335-7. Epub 2024 Feb 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38367631 Review.
Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review.
Catlett B, Hajarizadeh B, Cunningham E, Wolfson-Stofko B, Wheeler A, Khandaker-Hussain B, Feld JJ, Martró E, Chevaliez S, Pawlotsky JM, Bharat C, Cunningham PH, Dore GJ, Applegate T, Grebely J. Catlett B, et al. Among authors: wheeler a. J Infect Dis. 2022 Sep 21;226(6):1005-1021. doi: 10.1093/infdis/jiac049. J Infect Dis. 2022. PMID: 35150578
Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis.
Cunningham EB, Wheeler A, Hajarizadeh B, French CE, Roche R, Marshall AD, Fontaine G, Conway A, Valencia BM, Bajis S, Presseau J, Ward JW, Degenhardt L, Dore GJ, Hickman M, Vickerman P, Grebely J. Cunningham EB, et al. Among authors: wheeler a. Lancet Gastroenterol Hepatol. 2022 May;7(5):426-445. doi: 10.1016/S2468-1253(21)00471-4. Epub 2022 Mar 15. Lancet Gastroenterol Hepatol. 2022. PMID: 35303490
Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study.
Wheeler A, Valerio H, Cunningham EB, Martinello M, Barocas JA, Colledge-Frisby S, Treloar C, Amin J, Henderson C, Read P, Matthews GV, Dunlop AJ, Gorton C, Hayllar J, Alavi M, Murray C, Marks P, Silk D, Degenhardt L, Dore GJ, Grebely J; ETHOS Engage Study Group. Wheeler A, et al. Drug Alcohol Depend. 2022 Aug 1;237:109543. doi: 10.1016/j.drugalcdep.2022.109543. Epub 2022 Jun 26. Drug Alcohol Depend. 2022. PMID: 35772249
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis.
Cunningham EB, Wheeler A, Hajarizadeh B, French CE, Roche R, Marshall AD, Fontaine G, Conway A, Bajis S, Valencia BM, Presseau J, Ward JW, Degenhardt L, Dore GJ, Hickman M, Vickerman P, Grebely J. Cunningham EB, et al. Among authors: wheeler a. Int J Drug Policy. 2023 Jan;111:103917. doi: 10.1016/j.drugpo.2022.103917. Epub 2022 Dec 19. Int J Drug Policy. 2023. PMID: 36542883
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
Degenhardt L, Webb P, Colledge-Frisby S, Ireland J, Wheeler A, Ottaviano S, Willing A, Kairouz A, Cunningham EB, Hajarizadeh B, Leung J, Tran LT, Price O, Peacock A, Vickerman P, Farrell M, Dore GJ, Hickman M, Grebely J. Degenhardt L, et al. Among authors: wheeler a. Lancet Glob Health. 2023 May;11(5):e659-e672. doi: 10.1016/S2214-109X(23)00057-8. Epub 2023 Mar 27. Lancet Glob Health. 2023. PMID: 36996857 Free article.
Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review.
Colledge-Frisby S, Ottaviano S, Webb P, Grebely J, Wheeler A, Cunningham EB, Hajarizadeh B, Leung J, Peacock A, Vickerman P, Farrell M, Dore GJ, Hickman M, Degenhardt L. Colledge-Frisby S, et al. Among authors: wheeler a. Lancet Glob Health. 2023 May;11(5):e673-e683. doi: 10.1016/S2214-109X(23)00058-X. Epub 2023 Mar 27. Lancet Glob Health. 2023. PMID: 36996860 Free article.
Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, Australia.
Brothers TD, Lewer D, Jones N, Colledge-Frisby S, Bonn M, Wheeler A, Grebely J, Farrell M, Hickman M, Hayward A, Degenhardt L. Brothers TD, et al. Among authors: wheeler a. Int J Drug Policy. 2023 Dec;122:104218. doi: 10.1016/j.drugpo.2023.104218. Epub 2023 Oct 7. Int J Drug Policy. 2023. PMID: 37813083 Free article.
Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review.
Hajarizadeh B, Kairouz A, Ottaviano S, Ireland J, Willing A, Cunningham E, Webb P, Colledge-Frisby S, Wheeler A, Leung J, Tran LT, Price O, Vickerman P, Farrell M, Hickman M, Dore GJ, Bergenström A, Degenhardt L, Grebely J. Hajarizadeh B, et al. Among authors: wheeler a. Lancet Glob Health. 2023 Dec;11(12):e1885-e1898. doi: 10.1016/S2214-109X(23)00461-8. Lancet Glob Health. 2023. PMID: 37973339 Free article.
1,258 results